Health Care & Life Sciences » Biotechnology | U.S. Stem Cell Inc.

U.S. Stem Cell Inc.

U.S. Stem Cell Inc.
Stock Exchange Other OTC
EPS
$0.01
Market Cap
$3.62 M
Shares Outstanding
393.7 M
Public Float
337.13 M

Profile

Address
13794 NW 4th Street
Sunrise Florida 33325
United States
Employees -
Website http://www.us-stemcell.com
Updated 07/08/2019
U. S. Stem Cell, Inc. engages on the discovery, development, and subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.

Financials

View All

William P. Murphy
Chairman
Miguel Tomás
President, CEO, CFO & Director